These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29661022)

  • 1. Low Rates of Vaccination for Herpes Zoster in Older People Living With HIV.
    Erlandson KM; Streifel A; Novin AR; Hawkins KL; Foster C; Langness J; Bessesen M; Falutz J; Moanna A; Looney D; Johns ST; Nguyen JB; Oxman MN; Levin MJ
    AIDS Res Hum Retroviruses; 2018 Jul; 34(7):603-606. PubMed ID: 29661022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes Zoster and Herpes Zoster Vaccine Rates Among Adults Living With and Without HIV in the Veterans Aging Cohort Study.
    Hawkins KL; Gordon KS; Levin MJ; Weinberg A; Battaglia C; Rodriguez-Barradas MC; Brown ST; Rimland D; Justice A; Tate J; Erlandson KM;
    J Acquir Immune Defic Syndr; 2018 Dec; 79(4):527-533. PubMed ID: 30179984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential uptake of herpes zoster vaccination associated with socioeconomic status: A population-based study in Stockholm County, Sweden.
    Fogelberg S; Lamb F; Grönlund O; Eriksson I; Sundström K; Clements M; Arnheim-Dahlström L
    Pharmacoepidemiol Drug Saf; 2018 Nov; 27(11):1159-1165. PubMed ID: 30221421
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes zoster vaccine (HZV): utilization and coverage 2009 - 2013, Alberta, Canada.
    Liu XC; Simmonds KA; Russell ML; Svenson LW
    BMC Public Health; 2014 Oct; 14():1098. PubMed ID: 25342438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness and Duration of Protection Provided by the Live-attenuated Herpes Zoster Vaccine in the Medicare Population Ages 65 Years and Older.
    Izurieta HS; Wernecke M; Kelman J; Wong S; Forshee R; Pratt D; Lu Y; Sun Q; Jankosky C; Krause P; Worrall C; MaCurdy T; Harpaz R
    Clin Infect Dis; 2017 Mar; 64(6):785-793. PubMed ID: 28362955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti-TNF medications.
    Khan N; Shah Y; Trivedi C; Lewis JD
    Aliment Pharmacol Ther; 2017 Oct; 46(7):668-672. PubMed ID: 28805309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low willingness to vaccinate against herpes zoster in a Chinese metropolis.
    Lu X; Lu J; Zhang F; Wagner AL; Zhang L; Mei K; Guan B; Lu Y
    Hum Vaccin Immunother; 2021 Nov; 17(11):4163-4170. PubMed ID: 34370590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes zoster: vaccination status and virtuous experiences.
    Cocchio S; Gallo T; Baldo V
    Minerva Med; 2020 Feb; 111(1):4-8. PubMed ID: 32286762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The essential role of pharmacists facilitating vaccination in older adults: the case of Herpes Zoster.
    Tak CR; Marciniak MW; Savage A; Ozawa S
    Hum Vaccin Immunother; 2020; 16(1):70-75. PubMed ID: 31369322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with herpes zoster vaccination status and acceptance of vaccine recommendation in community pharmacies.
    Teeter BS; Garza KB; Stevenson TL; Williamson MA; Zeek ML; Westrick SC
    Vaccine; 2014 Sep; 32(43):5749-54. PubMed ID: 25171848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in Herpes Zoster Vaccination in Patients with Rheumatoid Arthritis: A Quality Improvement Project.
    Sheth H; Moreland L; Peterson H; Aggarwal R
    J Rheumatol; 2017 Jan; 44(1):11-17. PubMed ID: 28042124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The need for better preventative strategies for inflammatory bowel disease patients at risk of herpes zoster virus.
    Bye WA; Sparrow MP; Connor SJ; Andrews JM; Ellard K; Ng W; Hume G; Antoniades S; Walsh AJ
    Intern Med J; 2017 Nov; 47(11):1263-1269. PubMed ID: 28516725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving herpes zoster vaccine rates: The impact of a targeted educational program.
    OʼDonnell M; Shurpin K; Janotha B
    J Am Assoc Nurse Pract; 2018 Aug; 30(8):435-440. PubMed ID: 29905591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes zoster (HZ) vaccine coverage and confidence in Italy: a Nationwide cross-sectional study, the OBVIOUS project.
    Salussolia A; Capodici A; Scognamiglio F; La Fauci G; Soldà G; Montalti M; Di Valerio Z; Fantini MP; Odone A; Costantino C; Larson HJ; Leask J; Lenzi J; Gori D;
    BMC Infect Dis; 2024 Apr; 24(1):438. PubMed ID: 38658871
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of Live Attenuated Herpes Zoster Vaccine in Patients With Inflammatory Bowel Diseases.
    Khan N; Trivedi C; Kavani H; Medvedeva E; Lewis J; Yang YX
    Clin Gastroenterol Hepatol; 2019 Jun; 17(7):1341-1347. PubMed ID: 30326303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Multifaceted Intervention to Improve Influenza, Pneumococcal, and Herpes Zoster Vaccination among Patients with Rheumatoid Arthritis.
    Baker DW; Brown T; Lee JY; Ozanich A; Liss DT; Sandler DS; Ruderman EM
    J Rheumatol; 2016 Jun; 43(6):1030-7. PubMed ID: 27084914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Providers' lack of knowledge about herpes zoster in HIV-infected patients is among barriers to herpes zoster vaccination.
    Aziz M; Kessler H; Huhn G
    Int J STD AIDS; 2013 Jun; 24(6):433-9. PubMed ID: 23970744
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survey on public awareness, attitudes, and barriers for herpes zoster vaccination in South Korea.
    Yang TU; Cheong HJ; Song JY; Noh JY; Kim WJ
    Hum Vaccin Immunother; 2015; 11(3):719-26. PubMed ID: 25785481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessing and Improving Zoster Vaccine Uptake in a Homeless Population.
    Kaplan-Weisman L; Waltermaurer E; Crump C
    J Community Health; 2018 Dec; 43(6):1019-1027. PubMed ID: 29730833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: uptake of the first new vaccine to target seniors.
    Lu PJ; Euler GL; Jumaan AO; Harpaz R
    Vaccine; 2009 Feb; 27(6):882-7. PubMed ID: 19071175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.